Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu | (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats: 

  • Alabama Drug Discovery Alliance
  • Biochemistry and Molecular Genetics 
  • Biomatrix Engineering and Regenerative Medicine 
  • Cell biology 
  • Center for Biophysical Sciences and Engineering 
  • CCTS
  • Center for Metabolic Bone Disease 
  • Microbiology 
  • Neurobiology 
  • Comprehensive Neuroscience Center 
  • Pathology, research shared with MS2
  • Pharmacology and Toxicology 
  • Physiology and Biophysics 
  • UAB Research Foundation/IIE 
  • Research Administration
An Iowa college student with dreams of being a physician gleaned invaluable experience and inspiration out of a short summer the intensive research and clinical environment offered through UAB’s Biomedical Sciences Undergraduate Research Program.
Altered excitability is seen in brain neurons in epilepsy, depression, drug addiction and other disorders, and this discovery may offer a potential therapeutic target.

Kelly Walters relishes her access to scientists, clinicians and research opportunities unavailable to undergraduates at many other universities as she builds toward a career in medicine.  

UAB researchers have discovered that an infant’s airway — once thought to be sterile until after birth — is colonized by bacteria or bacterial DNA, which could be protective for or predict development of severe lung disease, knowledge that may offer a therapeutic target.
The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
Chang, who was named a 2015 Fulbright Scholar in 2015, is this year one of 57 Phi Kappa Phi fellows selected nationwide.
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
A quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.
The iKnife, a revolutionary mass spectrometry method, contributes to precision surgery by allowing accurate identification of cancer margins.
The ecRNAs appear to act in memory formation, and may offer a new therapeutic approach to neuropsychiatric diseases.
Page 44 of 52